XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of liabilities measured at fair value on the condensed consolidated balance sheet
The following are the liabilities measured at fair value on the condensed consolidated balance sheet at March 31, 2025 and December 31, 2024 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
Level 1:
Quoted Prices
in Active
Markets for Identical
Assets		Level 2:
Significant
Other
Observable
Inputs		Level 3:
Significant
Unobservable
Inputs		Total at March 31,
2025		Total Gains (Losses) For The Three Months Ended March 31, 2025
Recurring fair value measurements
2024 February Institutional/Accredited Investor warrants$— $— $73,670 $73,670 $217,896 
2024 October Institutional/Accredited Investor Warrants$— $— $27,056 $27,056 $265,178 
Senior Convertible Notes - October 2024$— $— $508,137 $508,137 $(1,091,006)
Additional Investment Rights - October 2024$— $— $682,667 $682,667 $(676,717)
2024 December Institutional/Accredited Investor Warrants$— $— $40,312 $40,312 $69,025 
2025 March Institutional/Accredited Investor Warrants$— $— $106,544 $106,544 $— 
Senior Convertible Notes - March 2025$— $— $1,393,456 $1,393,456 $— 
Total recurring fair value measurements$— $— $2,831,842 $2,831,842 $(1,215,624)
Level 1:
Quoted Prices
in Active
Markets for Identical
Assets		Level 2:
Significant
Other
Observable
Inputs		Level 3:
Significant
Unobservable
Inputs		Total at December 31,
2024		Total Gains (Losses) For The Three Months Ended March 31, 2024
Recurring fair value measurements
2022 July Institutional/Accredited Investor Warrants$— $— $— $— $4,619 
2024 February Institutional/Accredited Investor warrants$— $— $291,566 $291,566 $723,043 
2024 October Institutional/Accredited Investor Warrants$— $— $292,234 $292,234 $— 
Senior Convertible Notes - October 2024$— $— $2,475,162 $2,475,162 $— 
Additional Investment Rights - October 2024$— $— $5,950 $5,950 $— 
2024 December Institutional/Accredited Investor Warrants$— $— $109,337 $109,337 $— 
Derivative liability - non-controlling redeemable preferred shares$— $— $— $— $(11,533)
Total recurring fair value measurements$— $— $3,174,249 $3,174,249 $716,129 
Schedule of fair value on a recurring basis
The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2025:
Private warrants - February 20202024 February Institutional/Accredited Investor warrants2024 October Institutional/Accredited Investor WarrantsSenior Convertible Notes - October 2024Additional Investment Rights - October 20242024 December Institutional/Accredited Investor Warrants2025 March Institutional/Accredited Investor WarrantsSenior Convertible Notes - March 2025
Balance at December 31, 2024$— $291,566 $292,234 $2,475,162 $5,950 $109,337 $— $— 
Initial fair value— — — — — — 106,544 1,393,456 
Conversion of Convertible Notes— — — (3,058,031)— — — — 
Total (gains) losses for period included in earnings— (217,896)(265,178)1,091,006 676,717 (69,025)— — 
Balance at March 31, 2025$— $73,670 $27,056 $508,137 $682,667 $40,312 $106,544 $1,393,456